Skip to main content
Neuca S.A. logo

Neuca S.A. — Investor Relations & Filings

Ticker · NEU ISIN · PLTRFRM00018 LEI · 259400KFX90IZ97UDQ91 WAR Wholesale and retail trade
Open in API
Filings indexed 1,572 across all filing types
Latest filing 2017-03-16 Annual Report
Country PL Poland
Listing WAR NEU

About Neuca S.A.

https://www.neuca.pl/s/?language=en_GB

Neuca S.A. is a leader in the wholesale distribution of pharmaceuticals, operating as a comprehensive partner in the healthcare market. The company's core business involves supplying medicines to pharmacies. A key strategic principle is not owning any pharmacies, a conscious decision to avoid competing with its primary clients. Instead, the company focuses on supporting its strategic partners—independent pharmacists—by providing a range of tools and services designed to build their competitiveness and profitability. In addition to its primary distribution activities, the group is also engaged in the manufacturing of pharmaceuticals and the management of clinical trials through its specialized subsidiaries, offering a broad portfolio of services across the healthcare value chain.

Recent filings

Filing Released Lang Actions
Neuca_Opinia.pdf
Annual Report Classification · 100% confidence The document is a comprehensive financial report for Neuca S.A. for the fiscal year 2016. It includes the 'Sprawozdanie Finansowe' (Financial Statements), the 'Opinia Niezależnego Biegłego Rewidenta' (Independent Auditor's Report), and the 'Sprawozdanie z Działalności' (Management Report). Since it covers a full fiscal year and contains the complete set of financial statements and audit findings, it is classified as an Annual Report (10-K equivalent in this context). FY 2016
2017-03-16 Polish
List_prezesa.pdf
Audit Report / Information Classification · 95% confidence The document is a letter addressed to shareholders ("Drodzy Akcjonariusze") from the CEO of NEUCA SA, summarizing the performance, strategic activities, and outlook for the past year (2016) and looking ahead. It discusses market position, revenue milestones (e.g., 111 mln zł zysku netto), strategic investments (Świat Zdrowia, Pratia, Diabdis, Telemedycyna Polska), and overall business philosophy. This content structure—a high-level review of the past year's operations and financial achievements signed by the CEO—is characteristic of the narrative section found within a comprehensive Annual Report (10-K) or a standalone Annual Report (AR) if it were not a formal SEC filing. Given the context of a detailed review of the full fiscal year's performance, it strongly aligns with the content of an Annual Report. Since the text provided is a narrative summary/letter, and not explicitly stated as an 'Earnings Release' (ER) which is usually quarterly, or a 'Management Discussion and Analysis' (MDA) which is often a separate section, the most appropriate classification for a comprehensive yearly review letter is the Annual Report (10-K), assuming this is the primary document summarizing the year's activities. FY 2016
2017-03-16 Polish
Nabycie akcji własnych - Content (PL)
Transaction in Own Shares Classification · 98% confidence The document text explicitly states that the Management Board ('Zarząd') of NEUCA S.A. acquired its own shares ('nabyła akcji własnych') for the purpose of cancellation ('w celu umorzenia'). It details the number of shares, the price, and the resulting percentage of the share capital and voting rights held by the company in treasury. This action directly corresponds to the definition of a company buying back or selling its own shares, which maps to the 'Transaction in Own Shares' category.
2017-03-15 Polish
Nabycie akcji własnych - Content (PL)
Transaction in Own Shares Classification · 98% confidence The document text explicitly states that the Management Board ('Zarząd') of NEUCA S.A. acquired its own shares ('Spółka nabyła 585 akcji własnych w celu umorzenia') for the purpose of cancellation. It details the number of shares, the unit price, and the resulting percentage of the share capital and voting rights held as treasury stock. This action directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). Therefore, the appropriate classification is 'Transaction in Own Shares' (POS). The document length is very short (642 chars), but the content is a direct report of the transaction, not an announcement of a report's publication.
2017-03-14 Polish
Nabycie akcji własnych - Content (PL)
Transaction in Own Shares Classification · 98% confidence The document text explicitly states that the Management Board ('Zarząd') of NEUCA S.A. acquired its own shares ('nabyła 48 akcji własnych') for the purpose of cancellation ('w celu umorzenia'). It details the price, nominal value, and the resulting percentage of total capital and voting rights held in treasury shares. This action directly corresponds to the definition of a company buying back or selling its own shares (share repurchase/issuance). This matches the 'Transaction in Own Shares' category.
2017-03-13 Polish
Nabycie akcji własnych - Content (PL)
Transaction in Own Shares Classification · 98% confidence The document text explicitly states that the Company ('Spółka') acquired its own shares ('nabyła 401 akcji własnych') for the purpose of cancellation ('w celu umorzenia'). It details the number of shares acquired, the average price, and the resulting percentage of total share capital held by the company in treasury. This action directly corresponds to the definition of a company buying back or repurchasing its own shares. This matches the 'Transaction in Own Shares' category (POS). The document is short and reports a specific transaction, not an announcement of a report.
2017-03-10 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.